Home
Yezan Munther Haddadin, Director: Outlook Therapeutics OTLK Buy · Filed 24/03/29
Trade details
- Type
- Insider buy
- Amount
- $22,241.81
- Shares · price
- 1,881.71 sh · $11.82 a share
- Held after
- 5,048.71 sh
- Trade date
- 24/03/28
- Filed
- 24/03/29
- Days to filing
- 1 days
First buy since 2023
- Insiders buying this week
- 1 insiders
- Holding change
- +59.4%
Outlook Therapeutics trades, last 26 weeks
What else happened in Outlook Therapeutics around then
Filed or reported within 30 days of the trade day · 24/02/27~24/04/27Yezan Munther Haddadin's recent trades
- Yezan Munther Haddadin
BuyOutlook Therapeutics
BuyOutlook Therapeutics
OTLK
$24.1K
29,000 sh
$24.1K
Filed 06/03
Traded 06/02
- Yezan Munther Haddadin
BuyOutlook Therapeutics
BuyOutlook Therapeutics
OTLK
$15K
34,000 sh
$15K
Filed 05/27
Traded 05/26